J P Reckless
Overview
Explore the profile of J P Reckless including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
73
Citations
384
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Brudi P, Reckless J, Henry D, Pomykaj T, Lim S, Massaad R, et al.
Cardiology
. 2008 Nov;
113(2):89-97.
PMID: 19018143
Objective: The aim of the study was to compare the efficacy/safety of doubling the dose of low-, medium- and high-potency statins on lipids/lipoproteins versus ezetimibe/simvastatin (EZE/SIMVA) 10/40 mg in patients...
2.
Lawrence J, Reckless J
Hosp Med
. 2001 Aug;
62(7):411-6.
PMID: 11480129
Type 2 diabetes is increasingly common and can be difficult to control. By directly targeting insulin resistance, the thiazolidinediones offer a new mode of treatment. Here, the pharmacology, clinical trial...
3.
Lawrence J, Smith T, Iles D, Reckless J
J R Soc Med
. 2001 Jun;
94(7):349-50.
PMID: 11418708
No abstract available.
4.
Ballantyne C, Pazzucconi F, Pinto X, Reckless J, Stein E, McKenney J, et al.
Clin Ther
. 2001 Apr;
23(2):177-92.
PMID: 11293552
Background: At high doses, the pharmacokinetics of fluvastatin immediate-release (IR) are nonlinear, possibly due to saturation of hepatic uptake. Fluvastatin delivery to the liver in a slower but sustained fashion...
5.
Lawrence J, Reckless J
Int J Clin Pract
. 2001 Feb;
54(9):614-8.
PMID: 11220991
Pioglitazone is a thiazolidinedione. As a PPAR-gamma agonist it alters the expression of a number of genes, resulting in a reduction in insulin resistance. Clinical trial data involving over 4500...
6.
Jones S, Harris C, Lloyd J, Stirling C, Reckless J, McHugh N
Ann Rheum Dis
. 2000 Oct;
59(11):904-9.
PMID: 11053070
Objectives: (a) To characterise the lipid profile in psoriatic arthritis and investigate whether there are similarities to the dyslipoproteinaemia reported in rheumatoid arthritis and other inflammatory forms of joint disease;...
7.
Reckless J
Curr Opin Lipidol
. 2000 Aug;
11(4):351-6.
PMID: 10945715
The efficacy of lipid-lowering with statins has become clear. Indirect estimations, and direct measurements from long-term randomized trials have also demonstrated cost-effectiveness, both in secondary and primary prevention of coronary...
8.
Lye M, Valacio R, Reckless J, Ghosh A, Findlay I, Ghosh M, et al.
Coron Artery Dis
. 1998 Dec;
9(9):583-90.
PMID: 9861520
Background: Coronary heart disease is a major cause of morbidity and mortality in the elderly, a rapidly growing section of the population. Elderly patients have been excluded from most preventative...
9.
Reckless J
Curr Opin Lipidol
. 1996 Dec;
7(6):356-62.
PMID: 9117138
The effectiveness of cholesterol lowering is well established, but cost-effectiveness is an increasing issue because of financial pressures on healthcare services. New statin studies have prospectively demonstrated that secondary prevention...
10.